ERKNet

The European Rare Kidney Disease Reference Network

  

Journal Watch

Recently added publications

Rituximab in minimal change disease and focal segmental glomerulosclerosis.
Author(s): Kronbichler A, Gauckler P, Bruchfeld A
Source: Nephrol Dial Transplant 2019 Oct 3;
Publication date: 2019-10-3
Paediatric immune-mediated renal disease: an overview.
Author(s): Oni L
Source: Nephrol Dial Transplant 2019 Oct 5;
Publication date: 2019-10-5
Urinary Matrix Metalloproteinase 7 and Prediction of IgA Nephropathy Progression.
Author(s): Yang X, Ou J, Zhang H, Xu X, Zhu L, Li Q, Li J, Xie D, Sun J, Zha Y, Li Y, Tian J, Liu Y, Hou FF
Source: Am J Kidney Dis 2019 Oct 9;
Publication date: 2019-10-9
Treatment of hyperphosphatemia: the dangers of high PTH levels.
Author(s): Bacchetta J
Source: Pediatr Nephrol 2019 Nov 6;
Publication date: 2019-11-6
Histological prognostic factors in children with Henoch-Schönlein purpura nephritis.
Author(s): Delbet JD, Geslain G, Auger M, Hogan J, Salomon R, Peuchmaur M, Deschênes G, Buob D, Parmentier C, Ulinski T
Source: Pediatr Nephrol 2019 Nov 6;
Publication date: 2019-11-6



European Reference Networks
ERKNet is one of the 24 European Reference Networks (ERNs) approved by the ERN Board of Member States. The ERNs are co-funded by the European Commission.
For more information about the ERNs and the EU health strategy, please visit http://ec.europa.eu/health/ern